(CCK) Crown Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2283681060
Stock: Beverage Cans, Glass Bottles, Metal Closures, Protective Packaging
Total Rating 53
Risk 66
Buy Signal -0.76
| Risk 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Relative Tail Risk | -9.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 7.00 |
| Character TTM | |
|---|---|
| Beta | 0.284 |
| Beta Downside | 0.353 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.47 |
EPS (Earnings per Share)
Revenue
Description: CCK Crown Holdings March 05, 2026
Crown Holdings, Inc. (CCK) operates globally in the packaging industry. The company is a major producer of aluminum beverage cans, a product with high recycling rates in the packaging sector.
CCKs business model includes manufacturing various packaging solutions, such as glass bottles, food cans, and aerosol cans. The company also provides equipment and consumables for transit packaging, serving diverse industries including food, personal care, and industrial products.
The packaging sector is characterized by consistent demand driven by consumer goods consumption. Further research on ValueRay can provide deeper insights into CCKs market position and financial performance.
Headlines to watch out for
- Global beverage can demand drives revenue growth
- Aluminum and steel prices impact manufacturing costs
- Currency fluctuations affect international earnings
- Sustainable packaging trends boost market position
- Economic downturns reduce industrial packaging demand
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 737.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.00 > 1.0 |
| NWC/Revenue: 0.99% < 20% (prev 6.32%; Δ -5.33% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.51b > Net Income 737.0m |
| Net Debt (5.29b) to EBITDA (2.05b): 2.58 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.2m) vs 12m ago -3.68% < -2% |
| Gross Margin: 18.34% > 18% (prev 0.22%; Δ 1.81k% > 0.5%) |
| Asset Turnover: 87.94% > 50% (prev 85.22%; Δ 2.73% > 0%) |
| Interest Coverage Ratio: 4.00 > 6 (EBITDA TTM 2.05b / Interest Expense TTM 398.0m) |
Altman Z'' 1.98
| A: 0.01 (Total Current Assets 4.39b - Total Current Liabilities 4.27b) / Total Assets 14.27b |
| B: 0.27 (Retained Earnings 3.81b / Total Assets 14.27b) |
| C: 0.11 (EBIT TTM 1.59b / Avg Total Assets 14.06b) |
| D: 0.28 (Book Value of Equity 3.00b / Total Liabilities 10.79b) |
| Altman-Z'' Score: 1.98 = BBB |
Beneish M -2.88
| DSRI: 1.03 (Receivables 1.80b/1.67b, Revenue 12.37b/11.80b) |
| GMI: 1.17 (GM 18.34% / 21.52%) |
| AQI: 0.97 (AQ_t 0.32 / AQ_t-1 0.33) |
| SGI: 1.05 (Revenue 12.37b / 11.80b) |
| TATA: -0.05 (NI 737.0m - CFO 1.51b) / TA 14.27b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of CCK shares?
As of March 13, 2026, the stock is trading at USD 104.89 with a total of 777,895 shares traded.
Over the past week, the price has changed by -3.72%, over one month by -5.67%, over three months by +6.44% and over the past year by +18.57%.
Over the past week, the price has changed by -3.72%, over one month by -5.67%, over three months by +6.44% and over the past year by +18.57%.
Is CCK a buy, sell or hold?
Crown Holdings has received a consensus analysts rating of 4.27.
Therefore, it is recommended to buy CCK.
- StrongBuy: 8
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CCK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 129.7 | 23.6% |
| Analysts Target Price | 129.7 | 23.6% |
CCK Fundamental Data Overview March 11, 2026
P/E Trailing = 16.4765
P/E Forward = 12.7877
P/S = 0.9806
P/B = 3.9688
P/EG = 0.6365
Revenue TTM = 12.37b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 2.05b USD
Long Term Debt = 5.40b USD (from longTermDebt, last quarter)
Short Term Debt = 613.0m USD (from shortTermDebt, last quarter)
Debt = 6.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.29b USD (from netDebt column, last quarter)
Enterprise Value = 17.54b USD (12.13b + Debt 6.17b - CCE 764.0m)
Interest Coverage Ratio = 4.00 (Ebit TTM 1.59b / Interest Expense TTM 398.0m)
EV/FCF = 15.97x (Enterprise Value 17.54b / FCF TTM 1.10b)
FCF Yield = 6.26% (FCF TTM 1.10b / Enterprise Value 17.54b)
FCF Margin = 8.88% (FCF TTM 1.10b / Revenue TTM 12.37b)
Net Margin = 5.96% (Net Income TTM 737.0m / Revenue TTM 12.37b)
Gross Margin = 18.34% ((Revenue TTM 12.37b - Cost of Revenue TTM 10.10b) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 18.99%)
Tobins Q-Ratio = 1.23 (Enterprise Value 17.54b / Total Assets 14.27b)
Interest Expense / Debt = 1.54% (Interest Expense 95.0m / Debt 6.17b)
Taxrate = 26.64% (73.0m / 274.0m)
NOPAT = 1.17b (EBIT 1.59b * (1 - 26.64%))
Current Ratio = 1.03 (Total Current Assets 4.39b / Total Current Liabilities 4.27b)
Debt / Equity = 2.06 (Debt 6.17b / totalStockholderEquity, last quarter 3.00b)
Debt / EBITDA = 2.58 (Net Debt 5.29b / EBITDA 2.05b)
Debt / FCF = 4.82 (Net Debt 5.29b / FCF TTM 1.10b)
Total Stockholder Equity = 2.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 737.0m / Total Assets 14.27b)
RoE = 25.41% (Net Income TTM 737.0m / Total Stockholder Equity 2.90b)
RoCE = 19.19% (EBIT 1.59b / Capital Employed (Equity 2.90b + L.T.Debt 5.40b))
RoIC = 12.67% (NOPAT 1.17b / Invested Capital 9.22b)
WACC = 4.99% (E(12.13b)/V(18.30b) * Re(6.96%) + D(6.17b)/V(18.30b) * Rd(1.54%) * (1-Tc(0.27)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.33%
[DCF] Terminal Value 80.82% ; FCFF base≈974.4m ; Y1≈639.6m ; Y5≈291.8m
[DCF] Fair Price = 35.36 (EV 9.30b - Net Debt 5.29b = Equity 4.00b / Shares 113.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 16.22 | EPS CAGR: -3.77% | SUE: 0.21 | # QB: 0
Revenue Correlation: -29.50 | Revenue CAGR: -0.30% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.22 | Chg7d=-0.050 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=13
EPS current Year (2026-12-31): EPS=8.12 | Chg7d=-0.100 | Chg30d=-0.107 | Revisions Net=-6 | Growth EPS=+4.2% | Growth Revenue=+4.2%
EPS next Year (2027-12-31): EPS=8.90 | Chg7d=-0.102 | Chg30d=-0.118 | Revisions Net=+0 | Growth EPS=+9.7% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 7.9% - Earnings Yield 6.1%)
[Growth] Growth Spread = +2.4% (Analyst 4.2% - Implied 1.9%)
P/E Forward = 12.7877
P/S = 0.9806
P/B = 3.9688
P/EG = 0.6365
Revenue TTM = 12.37b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 2.05b USD
Long Term Debt = 5.40b USD (from longTermDebt, last quarter)
Short Term Debt = 613.0m USD (from shortTermDebt, last quarter)
Debt = 6.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.29b USD (from netDebt column, last quarter)
Enterprise Value = 17.54b USD (12.13b + Debt 6.17b - CCE 764.0m)
Interest Coverage Ratio = 4.00 (Ebit TTM 1.59b / Interest Expense TTM 398.0m)
EV/FCF = 15.97x (Enterprise Value 17.54b / FCF TTM 1.10b)
FCF Yield = 6.26% (FCF TTM 1.10b / Enterprise Value 17.54b)
FCF Margin = 8.88% (FCF TTM 1.10b / Revenue TTM 12.37b)
Net Margin = 5.96% (Net Income TTM 737.0m / Revenue TTM 12.37b)
Gross Margin = 18.34% ((Revenue TTM 12.37b - Cost of Revenue TTM 10.10b) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 18.99%)
Tobins Q-Ratio = 1.23 (Enterprise Value 17.54b / Total Assets 14.27b)
Interest Expense / Debt = 1.54% (Interest Expense 95.0m / Debt 6.17b)
Taxrate = 26.64% (73.0m / 274.0m)
NOPAT = 1.17b (EBIT 1.59b * (1 - 26.64%))
Current Ratio = 1.03 (Total Current Assets 4.39b / Total Current Liabilities 4.27b)
Debt / Equity = 2.06 (Debt 6.17b / totalStockholderEquity, last quarter 3.00b)
Debt / EBITDA = 2.58 (Net Debt 5.29b / EBITDA 2.05b)
Debt / FCF = 4.82 (Net Debt 5.29b / FCF TTM 1.10b)
Total Stockholder Equity = 2.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 737.0m / Total Assets 14.27b)
RoE = 25.41% (Net Income TTM 737.0m / Total Stockholder Equity 2.90b)
RoCE = 19.19% (EBIT 1.59b / Capital Employed (Equity 2.90b + L.T.Debt 5.40b))
RoIC = 12.67% (NOPAT 1.17b / Invested Capital 9.22b)
WACC = 4.99% (E(12.13b)/V(18.30b) * Re(6.96%) + D(6.17b)/V(18.30b) * Rd(1.54%) * (1-Tc(0.27)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.33%
[DCF] Terminal Value 80.82% ; FCFF base≈974.4m ; Y1≈639.6m ; Y5≈291.8m
[DCF] Fair Price = 35.36 (EV 9.30b - Net Debt 5.29b = Equity 4.00b / Shares 113.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 16.22 | EPS CAGR: -3.77% | SUE: 0.21 | # QB: 0
Revenue Correlation: -29.50 | Revenue CAGR: -0.30% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.22 | Chg7d=-0.050 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=13
EPS current Year (2026-12-31): EPS=8.12 | Chg7d=-0.100 | Chg30d=-0.107 | Revisions Net=-6 | Growth EPS=+4.2% | Growth Revenue=+4.2%
EPS next Year (2027-12-31): EPS=8.90 | Chg7d=-0.102 | Chg30d=-0.118 | Revisions Net=+0 | Growth EPS=+9.7% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 7.9% - Earnings Yield 6.1%)
[Growth] Growth Spread = +2.4% (Analyst 4.2% - Implied 1.9%)